SEC FORM 4
$19,997.58
Telix Pharmaceuticals Ltd (TLX)
Purchase of 2,071 shares at $9.656 per share.
Reporting Person Smith Darren Charlton · Officer Title Group Chief Financial Officer · Transaction Code P
Traded Sep 7, 2026 · Disclosed Sep 14, 2026FILED +7 DAYS
Source: SEC Form 4 · 0001628280-26-061944 · filed 2026-09-14 · View filing →